Careful planning, improving access to care, and managing pain, depression and side effects are logical paths to better oncology care. Three Precision for Value experts—Larry Blandford, Executive Vice President, Managing Partner; Maureen Hennessey, Senior Vice President, Director of Value Transformation; and Linda Bolland, Senior Advisor, explain how in the Journal of Clinical Pathways.
To read the full article, click here
The Precision Value & Health family of brands is now Precision AQ
Precision AQ helps life sciences companies navigate the complexities of commercialization across a product’s lifecycle. Our team is comprised of experts, advisors, and creators working to ensure patients have access to life-changing medicines.
Our global offerings include:
Our name, which stands for Precision Access Quotient, reflects our approach to removing barriers – fusing together science (IQ, or Intelligence Quotient) and empathy (EQ, or Emotional Quotient). The result is “AQ: Access Quotient”, a critical ingredient in navigating the therapy-to-patient journey informed by data-driven analytics and insights.
To find out more about our global services and our unified mission, empowering access to life-changing medicines for all, visit: Precision AQ
